TCR2 Therapeutics reports positive interim results for gavo-cel in early-stage solid tumors trial

TCR2 Therapeutics has reported positive interim results from its phase 1 part of the phase 1/2 clinical trial of its T-cell therapy candidate gavo-cel in ... Read More